Page 7 - Slrn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Slrn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Slrn Today - Breaking & Trending Today

Acelyrin (NASDAQ:SLRN) PT Raised to $39.00 at Morgan Stanley

Acelyrin (NASDAQ:SLRN – Free Report) had its price target lifted by Morgan Stanley from $29.00 to $39.00 in a research report report published on Tuesday morning, MarketBeat Ratings reports. The brokerage currently has an overweight rating on the stock. Several other research firms also recently issued reports on SLRN. Piper Sandler assumed coverage on Acelyrin […] ....

Piper Sandler , Hidradenitis Suppurativa , Jefferies Financial Group , Tower Research Capital , Osaic Holdings Inc , Morgan Stanley , Acelyrin Company Profile , Acelyrin Inc , York Mellon Corp , Free Report , Marketbeat Ratings , Financial Group , Get Free Report , Research Capital , New York Mellon Corp , Psoriatic Arthritis , Acelyrin Daily , Nasdaq Slrn , Boost Price Target ,

HC Wainwright Initiates Coverage on Acelyrin (NASDAQ:SLRN)

HC Wainwright started coverage on shares of Acelyrin (NASDAQ:SLRN – Free Report) in a research report sent to investors on Tuesday, MarketBeat Ratings reports. The firm issued a buy rating and a $44.00 price target on the stock. HC Wainwright also issued estimates for Acelyrin’s Q3 2023 earnings at ($0.29) EPS, Q4 2023 earnings at […] ....

Piper Sandler , Hidradenitis Suppurativa , Bio Partners , Morgan Stanley , Acelyrin Inc , Ayurmaya Capital Management Company , Acelyrin Company Profile , Jefferies Financial Group , Samsara Biocapital , Jpmorgan Chase Co , Free Report , Marketbeat Ratings , Financial Group , Get Free Report , Maya Capital Management Company , Psoriatic Arthritis , Acelyrin Daily , Nasdaq Slrn , Initiated Coverage , Hc Wainwright ,

Acelyrin (NASDAQ:SLRN) Shares Gap Up to $26.98

Shares of Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $26.98, but opened at $28.21. Acelyrin shares last traded at $27.05, with a volume of 81,925 shares changing hands. Analysts Set New Price Targets Several analysts have recently commented on the stock. […] ....

Hidradenitis Suppurativa , Piper Sandler , Morgan Stanley , Ayurmaya Capital Management Company , Jpmorgan Chase Co , Acelyrin Company Profile , Jefferies Financial Group , Artal Group , Acelyrin Inc , Bio Partners , Samsara Biocapital , Get Free Report , Financial Group , Trading Down , Maya Capital Management Company , Psoriatic Arthritis , Acelyrin Daily , Nasdaq Slrn ,